Литература/References
1. Wisner K. Safety bundle for severe hypertension during pregnancy and postpartum. MCN Am J Matern Child Nurs. 2018; 43 (3): 171.
2. Bernstein P.S., Martin J.N., Barton J.R., et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2017; 46 (5): 776–87.
3. Antwi E., Amoakoh-Coleman M., Vieira D.L., et al. Systematic review of prediction models for gestational hypertension and preeclampsia. PLoS One. 2020; 15 (4): e0230955.
4. Braunthal S., Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019; 7: 205031211984370.
5. Butalia S., Audibert F., Cote A.M., et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018; 34 (5): 526–31.
6. Tranquilli A.L., Dekker G., Magee L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014; 4 (2): 97–104.
7. Timalsina U., Andrasovich A., Kupferman F.E., Viswanathan K., Ericksen K. Reversal of opioid intoxication in an infant with intrauterine growth restriction with a single dose of naloxone. Cureus. 2021; 13 (10): e18908.
8. Chen C.-P., Lan F.-H., Chern S.-R. et al. Prenatal diagnosis of mosaic trisomy 16 by amniocentesis in a pregnancy associated with abnormal first-trimester screening result (low PAPP-A and low PlGF), intrauterine growth restriction and a favorable outcome. Taiwan J Obstet Gynecol. 2021; 60 (6): 1107–11.
9. Madden J.V., Flatley C.J., Kumar S. Term small-for-gestational-age infants from low-risk women are at significantly greater risk of adverse neonatal outcomes. Am J Obstet Gynecol. 2018; 218 (5): 525–59.
10. Szentpeteri I., Rab A., Kornya L., Kovács P., Brubel R., Joó J.G. Placental gene expression patterns of endoglin (CD105) in intrauterine growth restriction. J Matern Fetal Neonatal Med. 2014; 27 (4): 350–4.
11. Milnerowicz-Nabzdyk E., Bizon A. Effect of cigarette smoking on vascular flows in pregnancies complicated by intrauterine growth restriction. Reprod Toxicol. 2014; 50: 27–35.
12. Martin-Estal I., de la Garza R.G., Castilla-Cortazar I. Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency. Rev Physiol Biochem Pharmacol. 2016; 170: 1–35.
13. Zhu Y.-D., Bian J.-Y., Liao Y.-P., et al. Retrospective validation of 11–13 weeks’ gestation ultrasound characteristics as predictive tools for twin-twin transfusion syndrome and selective intrauterine growth restriction in monochorionic diamniotic twin pregnancies. Ann Transl Med. 2021; 9 (18): 1417.
14. Cyganek A., Pietrzak B., Kociszewska-Najman B., et al. Intrauterine growth restriction in pregnant renal and liver transplant recipients: risk factors assessment. Transplant Proc. 2014; 46 (8): 2794–7.
15. Wallenstein M.B., Harper L.M., Odibo A.O., et al. Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study. J Matern Fetal Neonatal Med. 2012; 25 (6): 662–5.
16. Bahtiyar M.O., Copel J.A. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol. 2008; 32 (3): 190–3.
17. Yeste N., Gómez N., Vázquez-Gómez M., et al. Polyphenols and IUGR pregnancies: intrauterine growth restriction and hydroxytyrosol affect the development and neurotransmitter profile of the hippocampus in a pig model. Antioxidants. 2021; 10 (10): 1505.
18. Jaeckle Santos L.J., Li C., Doulias P.T., Ischiropoulos H., Worthen G.S., Simmons R.A. Neutralizing Th2 inflammation in neonatal islets prevents β-cell failure in adult IUGR rats. Diabetes. 2014; 63 (5): 1672–84.
19. Rashid C.S., Lien Y.C., Bansal A., et al. Transcriptomic analysis reveals novel mechanisms mediating islet dysfunction in the intrauterine growth-restricted rat. Endocrinology. 2018; 159 (2): 1035–49.
20. Bahrami R., Schwartz D.A., Karimi-Zarchi M., et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turk J Obstet Gynecol. 2021; 18 (3): 236–44.
21. Simoncini S., Coppola H., Rocca A., et al. Endothelial colonyforming cells dysfunctions are associated with arterial hypertension in a rat model of intrauterine growth restriction. Int J Mol Sci. 2021; 22 (18): 10159.
22. Benítez-Marín M.J., Marín-Clavijo J., Blanco-Elena J.A., Jiménez-López J., González-Mesa E. Brain sparing effect on neurodevelopment in children with intrauterine growth restriction: a systematic review. Children. 2021; 8 (9): 745.
23. Ferrari F., Ferrari F.A., Negri B., et al. Uterine torsion and intrauterine growth restriction: case report and systematic literature review. J Obstet Gynaecol Res. 2021; 47 (12): 4224–31.
24. Brown A.S., Wieben M., Murdock S., et al. Intrauterine growth restriction causes abnormal embryonic dentate gyrus neurogenesis in mouse offspring that leads to adult learning and memory deficits. eNeuro. 2021; 8 (5): ENEURO.0062-21. 2021.
25. Ornoy A., Tsadok M.A., Yaffe P., Zangen S.W. The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reprod Toxicol. 2009; 28 (4): 521–9.
26. Gäreskog M., Eriksson U.J., Wentzel P. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res Pt A Clin Mol Teratol. 2006; 76 (6): 483–90.
27. Hafez S.M.N.A., Elbassuoni E., Abdelzaher W.Y., et al. Efficacy of vitamin E in protection against methotrexate induced placental injury in albino rats. Biomed Pharmacother. 2021; 139: 111637.
28. Bujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. Obstet Gynecol. 2010; 116 (2): 402–14.
29. Roberge S., Odibo A.O., Bujold R. Aspirin for the prevention of preeclampsia and intrauterine growth restriction. Clin Lab Med. 2016; 36 (2): 319–29.